Wendy's Co. Boosts FY21 Outlook; Raises Qtly Dividend 11% - Quick Facts

While reporting financial results for the first quarter on Wednesday, The Wendy's Co. (WEN) raised its adjusted earnings and global systemwide sales growth guidance for the full-year 2021. The company also raised its quarterly dividend 11% and increased share repurchase authorization.

For fiscal 2021, the company now projects adjusted earnings in a range of $0.72 to $0.74 per share on global systemwide sales growth of 8 to 10 percent, excluding the impact of the 53rd week.

Previously, the company expected adjusted earnings in the range of $0.67 to $0.69 per share on global systemwide sales growth of 6 to 8 percent, excluding the impact of the 53rd week.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $0.69 per share on revenue growth of 4.6 percent to $1.81 billion for the year. Analysts' estimates typically exclude special items.

The Company also announced a 11 percent increase in its regular quarterly cash dividend to 10 cents per share, payable on June 15, 2021, to stockholders of record as of June 1, 2021.

Further, the company announced that its Board of Directors has approved an increase to the Company's existing share repurchase authorization by $50 million to a total of $150 million after the Company exhausted its authorization due to favorable market conditions.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The 737 MAX 10, Boeing Co.'s largest 737 Max model, is taking its maiden flight today, reports said citing people familiar with the matter. The flight after months of testing and certification will be around 10 a.m. local time from the Seattle area. The schedule could change depending on weather or other factors. Meanwhile, the jetliner is expected to enter commercial service in 2023. Medical devices supplier Smiths Medical, affiliated to Smiths Group plc, is recalling certain Jelco Hypodermic Needle-Pro Fixed Needle insulin syringes with skewed graduation markings, the U.S. Food and Drug Administration said. The recall was initiated after the company became aware of specific models and lots of Jelco insulin syringes that may exhibit skewed odd number line graduation markings. Saliva-based COVID-19 testing is rolled out as a pilot for public schools in New York City. The new two-month pilot program is being implemented in about 50 New York City public schools and utilizes Fluidigm Technology to offer RT-PCR COVID-19 testing. New York City public schools have instituted mandatory random weekly testing in all reopened school buildings to ensure safer in-person learning.
Follow RTT